Extreme heat exposure in the first 1000 days: Implications for childhood stunting in Bangladesh
Public Health · 2025-04 · 241 · 83-88
DOI: 10.1016/j.puhe.2025.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health, 2025-04. Verfasst von Wameq Azfar Raza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health, Nutrition and Population Global Practice, World Bank. Plot E, 32 Syed Mahbub Morshed Avenue, Dhaka, 1207, Bangladesh. Electronic address: wra…. Hauptthemen laut MEDLINE: Growth Disorders, Extreme Heat. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Gates Foundation.
Abstract (Originalsprache)
OBJECTIVES: Stunting is a critical public health issue in Bangladesh, a country highly vulnerable to climate change and increased extreme heat exposure. Limited research has examined the relationship between extreme heat during the first 1000 days of life and stunting. This study provides the first evidence from Bangladesh on the likelihood of stunting among children aged 24-59 months following exposure to extreme heat during this crucial developmental period. STUDY DESIGN: The study utilized district-level panel data from the 2012 and 2019 Multiple Indicator Cluster Surveys, comprising of 24,035 children aged 24-59 months, paired with daily temperature records reflecting conditions from the child's firth 1000 days. METHODS: A multilevel logistic regression model with district-level random effects assessed the relationship between extreme heat exposure and stunting. RESULTS: A 1 % increase in extreme heat days during the first 1000 days of life was associated with higher odds of stunting (adjusted odds ratio [AOR] 1.56, 95 % confidence interval [CI] 1.25-1.95, p < 0.0001) at 24-59 months of age. Post-birth exposure to extreme heat showed a stronger association with stunting (AOR 1.67, 95 % CI 1.37-2.03, p = 0.063) than in utero exposure (AOR 1.28, 95 % CI 1.14-1.44, p < 0.0001). CONCLUSION: Escalating extreme heat threatens decades of progress in reducing stunting in Bangladesh. Mitigation efforts targeting the first 1000 days of life are critical, alongside further research to disentangle the specific effects of extreme heat on child growth within the broader context of climate change.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health, Nutrition and Population Global Practice, World Bank. Plot E, 32 Syed Mahbub Morshed Avenue, Dhaka, 1207, Bangladesh. Electronic address: wraza@worldbank.org.
- BRAC James P. Grant School of Public Health, BRAC University, 65 Mohakhali, Dhaka, 1213, Bangladesh.
- Institute of Statistical Research and Training, University of Dhaka, University Road, Dhaka, 1000, Bangladesh.
- Bangladesh Meteorological Department, Ministry of Environment, Forestry and Climate Change, Meteorological Complex Agargaon, Dhaka, 1207, Bangladesh.
- Bangladesh Agricultural University, BAU Main Road, Mymensingh, 2202, Bangladesh.
- Health, Nutrition and Population Global Practice, World Bank. 70, Lodi Estate, New Delhi, Delhi, 110003, India.
Förderung
- Gates Foundation
Zitieren
APA
Raza, W. A., Misha, F., Hossain, S. S., Gulshan, J., Rashid, B., Sayem, S. M., Aranya, S. G., & Chaudhery, D. (2025). Extreme heat exposure in the first 1000 days: Implications for childhood stunting in Bangladesh. Public Health, 241, 83-88. https://doi.org/10.1016/j.puhe.2025.02.002
Vancouver
Raza WA, Misha F, Hossain SS, Gulshan J, Rashid B, Sayem SM, et al. Extreme heat exposure in the first 1000 days: Implications for childhood stunting in Bangladesh. Public Health. 2025;241:83-88. doi:10.1016/j.puhe.2025.02.002
BibTeX
@article{Raza2025,
author = {Raza, Wameq Azfar and Misha, Farzana and Hossain, Syed Shahadat and Gulshan, Jahida and Rashid, Bazlur and Sayem, Sheikh Mohammad and Aranya, Souvik Ghosal and Chaudhery, Deepika},
title = {Extreme heat exposure in the first 1000 days: Implications for childhood stunting in Bangladesh},
journal = {Public Health},
year = {2025},
volume = {241},
pages = {83--88},
doi = {10.1016/j.puhe.2025.02.002}
}
EUVIMED